Need help? Call Us Now : 9456
Blog Details
Ethiopia Drew Nearly US$4 Billion in Foreign Investment. Why Is Healthcare Still Waiting?
Ethiopia Drew Nearly US$4 Billion in Foreign Investment. Why Is Healthcare Still Waiting?
Hospitals, diagnostics, medical equipment, pharmaceutical supply chains and digital-health services face a difficult path from investor interest to implementation.
By TENAWO Digital Health News Room
Addis Ababa | Special Report, June 26,2026
This story was supported by the Centre for Journalism Innovation and Development (CJID) with funding support from the Center for International Private Enterprise (CIPE).
Ethiopia attracted US$3.984 billion in foreign direct investment in 2024, up from US$3.269 billion in 2023. Yet healthcare, despite immense demand for hospitals, diagnostics, medicines, equipment and digital services, remains a small and poorly visible destination for foreign-backed investment.
A TENAWO Digital Health News Room review of public investment references, project disclosures, health-sector leads and stakeholder interviews found a clear mismatch: capital is entering Ethiopia, but healthcare is struggling to convert need into transparent, bankable and operational projects.
The reporting team reviewed 42 documents and datasets, coded 31 project records, completed 23 key-informant interviews, and identified seven health-sector investment leads.
The result is not a story about lack of need. It is a story about why need alone is not enough to attract and sustain investment.
Health Captures a Small Share of Visible Investment
TENAWO’s coded project dataset found that health and social services accounted for only two of 31 visible project records, or 7% of the total. Their estimated disclosed value was US$118 million, about 4.5% of the US$2.64 billion represented in the dataset.
By comparison, manufacturing and industrial projects made up 35% of the coded records, followed by energy and mining at 22%. Construction, agriculture, ICT, logistics and other commercial services also attracted more visible activity than health and social services.
This does not mean foreign investment is absent from Ethiopia. The data show the opposite: Ethiopia remains an important investment destination. The concern is that healthcare is not yet emerging as a major, transparent and scalable investment destination within that broader inflow.
The question is therefore not whether investors see Ethiopia. It is why they often do not see healthcare as a sufficiently predictable place to deploy long-term capital.
A High-Need Sector With Difficult Economics
Healthcare is different from many other sectors competing for investment.
Manufacturing and agro-processing can rely on export earnings and industrial incentives. Construction and real estate can rely on asset value. Energy and mining can benefit from clearer infrastructure or resource-based returns.
Healthcare, however, depends on many conditions working at the same time: imported equipment, skilled professionals, reliable electricity, patient affordability, insurance or public purchasing arrangements, quality regulation, medicines, supply chains and data protection.
Hospitals, laboratories, imaging centres and digital-health platforms require high upfront expenditure, but their returns may take longer to materialise. This makes the sector more sensitive to financing costs, currency movements and uncertainty around patient payment.
Ethiopia’s health-financing environment adds to this challenge. The report cites current health expenditure of approximately 2.8% of GDP and about US$34.8 per person in the latest available World Bank and WHO series.
For investors, the implication is direct: healthcare demand may be high, but the ability of households, insurers, employers and public institutions to pay predictably can remain uncertain.
Foreign Exchange Is the Largest Reported Barrier
Among the 23 interviewees, 78% identified foreign exchange and imported-equipment risk as a major barrier to health-sector investment.
Hospitals, diagnostic centres and medical suppliers depend on imported machines, spare parts, consumables and specialised equipment. Delays, exchange-rate pressure and import uncertainty can change project costs before a facility begins serving patients.
The second major barrier was patient affordability and weak purchasing power, cited by 70% of interviewees. Licensing and regulatory uncertainty followed at 65%, while health workforce constraints were cited by 57%.
The reporting team interviewed five government and regulatory actors, four private hospital or clinic representatives, four investors or financial institutions, four pharmaceutical or equipment suppliers, three digital-health companies and three civil-society or economic analysts.
Across these perspectives, the message was similar: healthcare is socially essential, but commercially uncertain unless financing, foreign exchange, infrastructure, workforce and regulation are addressed together.
Investor Interest Does Not Always Become a Functioning Project
TENAWO identified seven health-sector investment leads through interviews and public references.
Only two were operational or partially operational. Three were delayed or paused, while two remained at pre-feasibility or exploratory stage.
This is an important finding. It suggests that investor interest exists, but too few projects move smoothly from planning to implementation.
Projects can be delayed by foreign exchange pressure, licensing processes, high construction and equipment costs, weak payment certainty, land readiness, workforce shortages or unclear financing structures.
The report also found a strong urban concentration. Five of the seven health investment leads were focused on Addis Ababa or planned to enter Addis first.
Investors are attracted to the capital because it offers stronger purchasing power, specialist labour, referral networks, administrative access and relatively better infrastructure. But this raises an important public-interest question: will foreign-backed healthcare investment expand services nationally, or mainly strengthen premium urban markets?
The Transparency Gap
The report identifies another challenge: limited public access to sector-specific information.
It remains difficult for journalists, citizens and even potential investors to clearly track health-sector FDI approvals, disbursements, implementation status, investor origin and project outcomes.
Without this information, the public cannot easily determine:
- How much foreign investment has been approved for healthcare.
- Which projects have received financing.
- Which projects are operational, delayed or cancelled.
- Which regions are benefiting beyond Addis Ababa.
- Whether investment is improving affordability, quality, employment and access.
The lack of accessible information weakens accountability. It also makes it harder to identify investment-ready opportunities and learn from projects that did not move forward.
Questions That Require Answers
The final stage of this investigation should seek responses from major actors responsible for investment, health regulation, finance and project delivery.
The Ethiopian Investment Commission should be asked how many health-sector approvals have been issued since 2021, how many have reached implementation and why sector-level investment information is not more accessible.
Health authorities and regulators should clarify which subsectors and regions need investment most, how licensing timelines work and what safeguards protect patients from poor-quality or unaffordable services.
Finance and public-private partnership institutions should explain what guarantee mechanisms, blended-finance structures and public purchasing arrangements could reduce risk for responsible health investment.
Investors, banks and development-finance institutions should also answer a central question: what policy or market condition would make health projects more bankable than they are today?
What Could Change the Situation?
The findings point to practical steps that could help turn healthcare into a stronger investment destination without compromising patient protection, affordability or quality.
First, Ethiopia needs clearer public reporting on health-sector FDI approvals, disbursements and implementation status.
Second, policymakers and investors should prioritise investment-ready opportunities with clear public value, including diagnostics, biomedical equipment maintenance, pharmaceutical supply chains, regional referral services and digital-health infrastructure.
Third, the country needs better risk-sharing mechanisms. Blended finance, equipment guarantees and stronger public purchasing arrangements could help reduce the uncertainty that now slows high-priority health projects.
Finally, incentives should be linked to public-health outcomes: affordability, regional reach, workforce development, technology transfer, local maintenance capacity and quality care.
The Bottom Line
Ethiopia is attracting foreign capital. But healthcare is still receiving too little of it in a visible, scalable and publicly accountable form.
The problem is not a lack of health need. The problem is that health need has not yet been translated into enough transparent, investable and operationally viable projects.
For Ethiopia, the opportunity is significant. Responsible investment in hospitals, diagnostics, pharmaceutical supply chains, medical technology, homecare and digital health could improve access, create skilled jobs, strengthen local capacity and reduce the financial burden of illness for millions of families.
The question now is whether Ethiopia can build the financing, regulatory clarity, transparency and accountability needed to make that investment possible.
References link